Inhibitor Therapeutics, Inc. (INTI) SEC Filings https://investors.inhibitortx.com/sec-filings/annual-reports/rss Inhibitor Therapeutics, Inc. (INTI) - Annual Reports en-us https://d1io3yog0oux5.cloudfront.net/_5a8cb0b9c83c9803ac6e80d95e72f0b2/inhibitortx/files/theme/images/logo-sm.png Inhibitor Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-012751/0001493152-26-012751.pdf Thu, 26 Mar 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-012751/0001493152-26-012751.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-001190/0001641172-25-001190.pdf Fri, 28 Mar 25 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-001190/0001641172-25-001190.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-011973/0001493152-24-011973.pdf Fri, 29 Mar 24 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-011973/0001493152-24-011973.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-23-010383/0001493152-23-010383.pdf Fri, 31 Mar 23 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-23-010383/0001493152-23-010383.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-22-088832/0001193125-22-088832.pdf Wed, 30 Mar 22 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-22-088832/0001193125-22-088832.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-21-095516/0001193125-21-095516.pdf Fri, 26 Mar 21 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-21-095516/0001193125-21-095516.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-20-090201/0001193125-20-090201.pdf Mon, 30 Mar 20 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-20-090201/0001193125-20-090201.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-19-066503/0001193125-19-066503.pdf Thu, 07 Mar 19 00:00:00 -0500 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-19-066503/0001193125-19-066503.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-18-047834/0001193125-18-047834.pdf Fri, 16 Feb 18 00:00:00 -0500 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-18-047834/0001193125-18-047834.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-17-048025/0001193125-17-048025.pdf Fri, 17 Feb 17 00:00:00 -0500 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-17-048025/0001193125-17-048025.pdf